Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

An open trial of rolling admission mindfulness-based relapse prevention (Rolling MBRP): feasibility, acceptability, dose-response relations, and mechanisms.

Roos C, Kirouac M, Stein E, Wilson A, Bowen S, Witkiewitz K.

Mindfulness (N Y). 2019 Jun;10(6):1062-1073. doi: 10.1007/s12671-018-1054-5. Epub 2018 Nov 12.

PMID:
31354877
2.

Consumption outcomes in clinical trials of alcohol use disorder treatment: Consideration of standard drink misestimation.

Kirouac M, Kruger E, Wilson AD, Hallgren KA, Witkiewitz K.

Am J Drug Alcohol Abuse. 2019;45(5):451-459. doi: 10.1080/00952990.2019.1584202. Epub 2019 Mar 14.

3.

Predictive value of non-consumption outcome measures in alcohol use disorder treatment.

Kirouac M, Witkiewitz K.

Addiction. 2019 Jun;114(6):1086-1092. doi: 10.1111/add.14553. Epub 2019 Feb 6.

PMID:
30650471
4.

Abstinence and low risk drinking during treatment: Association with psychosocial functioning, alcohol use, and alcohol problems 3 years following treatment.

Witkiewitz K, Kirouac M, Roos CR, Wilson AD, Hallgren KA, Bravo AJ, Montes KS, Maisto SA.

Psychol Addict Behav. 2018 Sep;32(6):639-646. doi: 10.1037/adb0000381. Epub 2018 Aug 30.

5.

Profiles of recovery from alcohol use disorder at three years following treatment: can the definition of recovery be extended to include high functioning heavy drinkers?

Witkiewitz K, Wilson AD, Pearson MR, Montes KS, Kirouac M, Roos CR, Hallgren KA, Maisto SA.

Addiction. 2019 Jan;114(1):69-80. doi: 10.1111/add.14403. Epub 2018 Aug 24.

6.
7.

"Being able to speak": What individuals in jail perceived as helpful about participating in alcohol-related brief interventions.

Owens MD, Kirouac M, Hagler K, Rowell LN, Williams EC.

Subst Abus. 2018;39(3):342-347. doi: 10.1080/08897077.2017.1393034. Epub 2017 Dec 5.

8.

Viability of the World Health Organization quality of life measure to assess changes in quality of life following treatment for alcohol use disorder.

Kirouac M, Stein ER, Pearson MR, Witkiewitz K.

Qual Life Res. 2017 Nov;26(11):2987-2997. doi: 10.1007/s11136-017-1631-4. Epub 2017 Jun 24.

9.

Identifying "Hitting Bottom" Among Individuals with Alcohol Problems: Development and Evaluation of the Noteworthy Aspects of Drinking Important to Recovery (NADIR).

Kirouac M, Witkiewitz K.

Subst Use Misuse. 2017 Oct 15;52(12):1602-1615. doi: 10.1080/10826084.2017.1293104. Epub 2017 May 30.

10.

Who achieves low risk drinking during alcohol treatment? An analysis of patients in three alcohol clinical trials.

Witkiewitz K, Pearson MR, Hallgren KA, Maisto SA, Roos CR, Kirouac M, Wilson AD, Montes KS, Heather N.

Addiction. 2017 Dec;112(12):2112-2121. doi: 10.1111/add.13870. Epub 2017 Jun 26.

11.

The search for an elusive cutoff remains: Problems of binary classification of heavy drinking as an endpoint for alcohol clinical trials.

Pearson MR, Bravo AJ, Kirouac M, Witkiewitz K.

Drug Alcohol Depend. 2017 Feb 1;171:91-96. doi: 10.1016/j.drugalcdep.2016.11.015. Epub 2016 Nov 22.

12.

How Much Is Too Much? Patterns of Drinking During Alcohol Treatment and Associations With Post-Treatment Outcomes Across Three Alcohol Clinical Trials.

Witkiewitz K, Roos CR, Pearson MR, Hallgren KA, Maisto SA, Kirouac M, Forcehimes AA, Wilson AD, Robinson CS, McCallion E, Tonigan JS, Heather N.

J Stud Alcohol Drugs. 2017 Jan;78(1):59-69.

13.

Questioning the validity of the 4+/5+ binge or heavy drinking criterion in college and clinical populations.

Pearson MR, Kirouac M, Witkiewitz K.

Addiction. 2016 Oct;111(10):1720-6. doi: 10.1111/add.13210. Epub 2015 Dec 28. Review.

14.

Client Evaluation of Treatment for Alcohol Use Disorder in COMBINE.

Kirouac M, Witkiewitz K, Donovan DM.

J Subst Abuse Treat. 2016 Aug;67:38-43. doi: 10.1016/j.jsat.2016.04.007. Epub 2016 May 9.

15.

Religious Affiliation and Spiritual Practices: An Examination of the Role of Spirituality in Alcohol Use and Alcohol Use Disorder.

Witkiewitz K, McCallion E, Kirouac M.

Alcohol Res. 2016;38(1):55-8. Review. No abstract available.

16.

We still question the utility and validity of the binge/heavy drinking criterion.

Pearson MR, Kirouac M, Witkiewitz K.

Addiction. 2016 Oct;111(10):1733-4. doi: 10.1111/add.13384. Epub 2016 May 3. No abstract available.

17.

Association between physical pain and alcohol treatment outcomes: The mediating role of negative affect.

Witkiewitz K, McCallion E, Vowles KE, Kirouac M, Frohe T, Maisto SA, Hodgson R, Heather N.

J Consult Clin Psychol. 2015 Dec;83(6):1044-57. doi: 10.1037/ccp0000033. Epub 2015 Jun 22.

18.

Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial.

Witkiewitz K, Vowles KE, McCallion E, Frohe T, Kirouac M, Maisto SA.

Addiction. 2015 Aug;110(8):1262-71. doi: 10.1111/add.12964. Epub 2015 Jun 3.

19.

Examining temptation to drink from an existential perspective: Associations among temptation, purpose in life, and drinking outcomes.

Roos CR, Kirouac M, Pearson MR, Fink BC, Witkiewitz K.

Psychol Addict Behav. 2015 Sep;29(3):716-24. doi: 10.1037/adb0000063. Epub 2015 Mar 2.

20.

The indirect effect of the therapeutic alliance and alcohol abstinence self-efficacy on alcohol use and alcohol-related problems in Project MATCH.

Maisto SA, Roos CR, O'Sickey AJ, Kirouac M, Connors GJ, Tonigan JS, Witkiewitz K.

Alcohol Clin Exp Res. 2015 Mar;39(3):504-13. doi: 10.1111/acer.12649. Epub 2015 Feb 19.

21.

Randomized controlled trial of web-based decisional balance feedback and personalized normative feedback for college drinkers.

Collins SE, Kirouac M, Lewis MA, Witkiewitz K, Carey KB.

J Stud Alcohol Drugs. 2014 Nov;75(6):982-92.

22.

Alcohol use disorder clinical course research: informing clinicians' treatment planning now and in the future.

Maisto SA, Kirouac M, Witkiewitz K.

J Stud Alcohol Drugs. 2014 Sep;75(5):799-807. Review.

23.

Advantages and disadvantages of college drinking in students' own words: content analysis of the decisional balance worksheet.

Collins SE, Kirouac M, Taylor E, Spelman PJ, Grazioli V, Hoffman G, Haelsig L, Holttum J, Kanagawa A, Nehru M, Hicks J.

Psychol Addict Behav. 2014 Sep;28(3):727-33. doi: 10.1037/a0036354. Epub 2014 Aug 18.

PMID:
25134033
24.

Development and evaluation of a mobile intervention for heavy drinking and smoking among college students.

Witkiewitz K, Desai SA, Bowen S, Leigh BC, Kirouac M, Larimer ME.

Psychol Addict Behav. 2014 Sep;28(3):639-50. doi: 10.1037/a0034747. Epub 2014 Jul 7.

25.

Project-based Housing First for chronically homeless individuals with alcohol problems: within-subjects analyses of 2-year alcohol trajectories.

Collins SE, Malone DK, Clifasefi SL, Ginzler JA, Garner MD, Burlingham B, Lonczak HS, Dana EA, Kirouac M, Tanzer K, Hobson WG, Marlatt GA, Larimer ME.

Am J Public Health. 2012 Mar;102(3):511-9. doi: 10.2105/AJPH.2011.300403. Epub 2012 Jan 19.

26.

Exploring transitions within a project-based Housing First setting: qualitative evaluation and practice implications.

Collins SE, Clifasefi SL, Andrasik MP, Dana EA, Stahl N, Kirouac M, Welbaum C, King M, Malone DK.

J Health Care Poor Underserved. 2012 Nov;23(4):1678-97. doi: 10.1353/hpu.2012.0187.

27.

Where harm reduction meets housing first: exploring alcohol's role in a project-based housing first setting.

Collins SE, Clifasefi SL, Dana EA, Andrasik MP, Stahl N, Kirouac M, Welbaum C, King M, Malone DK.

Int J Drug Policy. 2012 Mar;23(2):111-9. doi: 10.1016/j.drugpo.2011.07.010. Epub 2011 Aug 17.

28.

Preventing Relapse Following Smoking Cessation.

Collins SE, Witkiewitz K, Kirouac M, Marlatt GA.

Curr Cardiovasc Risk Rep. 2010 Nov;4(6):421-428.

29.

A mechanical force contributes to the "osmotic swelling" of brush-border membrane vesicles.

Kirouac M, Vachon V, Fortier M, Trudel MC, Berteloot A, Schwartz JL, Laprade R.

Biophys J. 2006 Nov 1;91(9):3301-12. Epub 2006 Aug 11.

30.

Differential effects of ionic strength, divalent cations and pH on the pore-forming activity of Bacillus thuringiensis insecticidal toxins.

Fortier M, Vachon V, Kirouac M, Schwartz JL, Laprade R.

J Membr Biol. 2005 Nov;208(1):77-87.

PMID:
16596448
31.
32.

Analysis of the properties of Bacillus thuringiensis insecticidal toxins using a potential-sensitive fluorescent probe.

Kirouac M, Vachon V, Rivest S, Schwartz JL, Laprade R.

J Membr Biol. 2003 Nov 1;196(1):51-9.

PMID:
14724756
33.

Gene expression markers for Caenorhabditis elegans vulval cells.

Inoue T, Sherwood DR, Aspöck G, Butler JA, Gupta BP, Kirouac M, Wang M, Lee PY, Kramer JM, Hope I, Bürglin TR, Sternberg PW.

Mech Dev. 2002 Dec;119 Suppl 1:S203-9.

35.

Gene expression markers for Caenorhabditis elegans vulval cells.

Inoue T, Sherwood DR, Aspöck G, Butler JA, Gupta BP, Kirouac M, Wang M, Lee PY, Kramer JM, Hope I, Bürglin TR, Sternberg PW.

Gene Expr Patterns. 2002 Dec;2(3-4):235-41.

PMID:
12617807
36.

Amino acid and divalent ion permeability of the pores formed by the Bacillus thuringiensis toxins Cry1Aa and Cry1Ac in insect midgut brush border membrane vesicles.

Kirouac M, Vachon V, Noël JF, Girard F, Schwartz JL, Laprade R.

Biochim Biophys Acta. 2002 Apr 12;1561(2):171-9.

37.
38.

[Function of a multidisciplinarian mini-team in the treatment of drug addiction].

Blanchette M, Kirouac M, Desrochers CY, Marcoux G.

Infirm Can. 1973 Jul;15(7):12-6. French. No abstract available.

PMID:
4489620

Supplemental Content

Loading ...
Support Center